Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis

Apoptosis

Volumn 16, Issue 7, 2011, Pages 653-659

  Musia, Kinga ^a   Zwolińska, Danuta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Hemodialysis; MMP 7; Peritoneal dialysis; TIMP 1

Indexed keywords

FAS LIGAND; GELATINASE A; GELATINASE B; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADOLESCENT; APOPTOSIS; ARTICLE; CELL DEATH; CHILD; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REGULATORY MECHANISM; SCHOOL CHILD;

ADOLESCENT; ANTIGENS, CD95; APOPTOSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASES; PERITONEAL DIALYSIS; REGRESSION ANALYSIS; RENAL DIALYSIS; SOLUBILITY; TISSUE INHIBITOR OF METALLOPROTEINASES; YOUNG ADULT;

EID: 80051544834     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-011-0604-2     Document Type: Article

References (31)

1. Andreoli MCC, Dalboni MA, Watanabe R, Manfredi SR, Canziani MEF, Kallas EG, Sesso RC, Draibe SA, Balakrishnan VS, Jaber BL, Liangos O, Cendoroglo M (2007) Impact of dialyzer membrane on apoptosis and function of polymorphonuclear cells and cytokine synthesis by peripheral blood mononuclear cells in hemodialysis patients. Artif Org 31:887-910
2. Soriano S, Martin-Malo A, Carracedo J, Ramirez R, Rodriguez M, Aljama P (2005) Lymphocyte apoptosis: role of uremia and permeability of dialysis membrane. Nephron Clin Pract 100: c71-c77 (Pubitemid 40868988)
3. Nagata S, Goldstein P (1995) The Fas death factor. Science 267:1449-1456
4. Yang Z, Gagarin D, Ramezani A, Hawley RG, McCaffrey TA (2007) Resistance to Fas-induced apoptosis in cells from human atherosclerotic lesions: elevated Bcl-XL inhibits apoptosis and caspase activation. J Vasc Res 44:483-494 (Pubitemid 350022322)
5. McCaffrey TA, Du B, Fu Ch, Bray PJ, Sanborn TA, Deutsch E, Tarazona N, Shaknovitch A, Newman G, Patterson C, Bush HL Jr (1999) The expression of TGF-b receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance. J Mol Cell Cardiol 31:1627-1642 (Pubitemid 29414583)
6. Clarke MC, Figg N, Maguire JJ, Davenport AP, Goddard M, Littlewood TD, Bennett MR (2006) Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 12:1075-1080 (Pubitemid 44353389)
7. Matter ChM, Chadjichristos ChE, Meier P, von Lukowicz T, Lohmann Ch, Schuler PK, Zhang D, Odermatt B, Hofmann E, Brunner T, Kwak BR, Luescher T (2006) Role for endogenous Fas (CD95/Apo-1) ligand in balloon-induced apoptosis, inflammation, and neointima formation. Circulation 113:1879-1887 (Pubitemid 43739400)
8. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H (1995) Metalloproteinasemediated release of human Fas ligand. J Exp Med 182:1777-1783
9. Vargo-Gogola T, Crawford HC, Fingleton B, Matrisian LM (2002) Identification of novel matrix metalloproteinase-7 (matrilysin) cleavage sites in murine and human Fas ligand. Arch Biochem Biophys 408:155-161 (Pubitemid 36027034)
10. Poulaki V, Mitsiades CS, Mitsiades N (2001) The role of Fas and FasL as mediators of anticancer chemotherapy. Drug Resist Updates 4:233-242 (Pubitemid 34456377)
11. Liu H, Huang J, Wu B, Zhou Y, Zhu J, Zhang T (2008) Matrilysin inhibits proliferation and modulates sensitivity of lung cancer cells to FasL-mediated apoptosis. Med Oncol 25:419-430
12. Tsukinoki T, Sugiyama H, Sunami R, Kobayashi M, Onoda T, Maeshima Y, Yamasaki Y, Makino H (2004) Mesangial cell Fas ligand: upregulation in human lupus nephritis and NF-jB-mediated expression in cultured human mesangial cells. Clin Exp Nephrol 8:196-205 (Pubitemid 39421368)
13. Schneider P, Holler N, Bodmer JL, Hahne M, Frei K, Fontana A, Tschopp J (1998) Conversion of membrane-bound Fas (CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J Exp Med 187:1205-1213 (Pubitemid 28189110)
14. Tanaka M, Itai T, Adachi M, Nagata S (1998) Downregulation of Fas ligand by shedding. Nat Med 4:31-36 (Pubitemid 28133076)
15. El-Agroudy AE, El-Baz A (2010) Soluble Fas: a useful marker of inflammation and cardiovascular diseases in uremic patients. Clin Exp Nephrol 14:152-157
16. Dalboni MA, Sardenberg C, Andreoli MC, Watanabe R, Canziani ME, dos Santos BFC, Liangos OL, Jaber BL, Draibe S, Cendoroglo M (2003) Soluble Fas: a novel marker of inflammation in uremia. Artif Org 27:687-691 (Pubitemid 37041377)
17. Wang T, Dong Ch, Stevenson SC, Herderick EE, Marshall-Neff J, Vasudevan SS, Moldovan NI, Michler RE, Movva NR, Goldschmidt-Clermont PJ (2002) Overexpression of soluble Fas attenuates transplant arteriosclerosis in rat aortic allografts. Circulation 106:1536-1542
18. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
19. Perianayagam MC, Murray SL, Balakrishnan VS, Guo D, King AJ, Pereira BJG, Jaber BL (2000) Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure. J Lab Clin Med 136:320-327
20. Goes MA, Dalboni MA, Manfredi SR, Cendoroglo MS, Batista MC, Canziani ME, Balakrishnan VS, Pereira BJ, Draibe SA, Cendoroglo M (2010) Serum-soluble Fas and serum levels of erythropoietin in chronic kidney disease. Clin Nephrol 73:7-13
21. Dalboni MA, Cenedeze MA, Manfredi SR, Cruz Andreoli MC, Pavao Dos Santos O, Canziani ME, Boim MA, Goes MA, Draibe SA, Balakrishnan V, Cendoroglo M (2008) High serum levels of soluble Fas (sFas) in CKD patients: effects of renal clearance, reabsorption and synthesis. Int J Artif Organs 31:405-410 (Pubitemid 351983353)
22. Seishima M, Takemura M, Saito K, Sano H, Minatoguchi S, Fujiwara H, Hachiya T, Noma A (1996) Highly sensitive ELISA for soluble Fas in serum: increased soluble Fas in the elderly. Clin Chem 42:1911-1914 (Pubitemid 26415338)
23. Masse M, Hebert MJ, Troyanov S, Vigneault N, Sirois I, Madore F (2002) Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients. Nephrol Dial Transplant 17:485-491 (Pubitemid 34211148)
24. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Canziani MEF (2006) Coronary artery calcification, systemic inflammation markers an mineral metabolism in a peritoneal dialysis population. Nephron Clin Pract 104:c33-c40
25. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, Weissberg PL (2000) Apoptosis regulates human vascular calcification in vitro. Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87:1055-1062
26. Kirmizis D, Papagianni A, Belechri AM, Memmos D (2010) Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis. Nephrol Dial Transplant. doi:10.1093/ndt/ gfq715
27. Jaber BL, Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ (2001) Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J Leukoc Biol 69:1006-1012 (Pubitemid 32577904)
28. O'Reilly LA, Tai L, Lee L, Kruse EA, Grabow S, Fairlie D, Haynes NM, Tarlinton DM, Zhang JG, Belz GT, Smyth MJ, Bouillet P, Robb L, Strasser A (2009) Membrane-bound but not secreted Fas ligand is essential for Fas-induced apoptosis and prevention of autoimmunity and cancer. Nature 461:659-663
29. Musiał K, Zwolińska D (2011) Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis. Cell Stress Chaperones 16:163-171
30. Nalla AK, Gorantla B, Gondi CS, Lakka SS, Rao JS (2010) Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Ther 17:599-613
31. Cheng J, Zhou T, Liu C, Shapiro JP, Brauer MJ, Kiefer MC, Barr PJ, Mountz JD (1994) Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science 263:1759-1762 (Pubitemid 24131584)